Showing results (11-20 of 118) with videos related to
Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNAJonathan E Zuckerman, Ismael Gritli, Anthony Tolcher, et al.Nucleic Acids Research|July 29, 2005
Functional polarity is introduced by Dicer processing of short substrate RNAsScott D Rose, Dong-Ho Kim, Mohammed Amarzguioui, et al.Proceedings of the National Academy of Sciences of the United States of America|March 24, 2007
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNAJeremy D Heidel, Zhongping Yu, Joanna Yi-Ching Liu, et al.Nature|March 23, 2010
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesMark E Davis, Jonathan E Zuckerman, Chung Hang J Choi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivoJeremy D Heidel, Joanna Yi-Ching Liu, Yun Yen, et al.Nature Medicine|October 6, 2009
Development of universal antidotes to control aptamer activitySabah Oney, Ruby T S Lam, Kristin M Bompiani, et al.Molecular Pharmaceutics|March 10, 2009
The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinicMark E DavisAdvanced Drug Delivery Reviews|August 18, 2009
Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecinMark E DavisPageof 12